Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Maria Bucek Psenkova"'
Autor:
Barnaby Hunt, Natalia Racekova, Tom Vandebrouck, Antonio Ramírez de Arellano, Maria Bucek Psenkova, Marek Psota
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
Marek Psota,1 Maria Bucek Psenkova,1 Natalia Racekova,2 Antonio Ramirez de Arellano,3 Tom Vandebrouck,4 Barnaby Hunt5 1Pharm-In, Ltd., 2Novo Nordisk Ltd., Bratislava, Slovakia; 3Novo Nordisk Ltd., Madrid, Spain; 4Novo Nordisk nv, Brussels, Belgium; 5
Autor:
Marek Psota, Maria Avdicova, Jarmila Pekarčíková, Martin Studencan, Martin O'Flaherty, Simon Capewell, Maria Bucek Psenkova, Eva Goncalvesova, Piotr Bandosz
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0190090 (2018)
PLoS ONE
PLoS ONE
Objective Between the years 1993 and 2008, mortality rates from coronary heart disease (CHD) in the Slovak Republic have decreased by almost one quarter. However, this was a smaller decline than in neighbouring countries. The aim of this modelling st
Publikováno v:
Value in health regional issues. 13
Slovak law sets clear rules and timelines in the process of approving the price and reimbursement of drugs. During the last decade, the Ministry of Health adopted several cost-containment measures in the price and reimbursement policy. The most effec
Publikováno v:
Value in Health. 19:A674
Autor:
Stanislava Mackovicova, Maria Bucek Psenkova, Tatiana Foltanova, Alexander Palúch, Lenka Petrová
Publikováno v:
European Medical, Health and Pharmaceutical Journal. 3
The disabling nature and lifelong impact of multiple sclerosis (MS) imposes considerable socioeconomic burden despite its relative low prevalence compared to other chronic diseases. This is the first study of MS in the Slovak Republic that provides i